Skip to main content
. 2022 Aug 4;13:954268. doi: 10.3389/fimmu.2022.954268

Figure 2.

Figure 2

Forest plots of ORRs at any time (A) and day 28 (B) after ruxolitinib treatment in SR-aGVHD and the ORRs at any time (C) and week 24 (D) after ruxolitinib treatment in SR-cGVHD.